Dexamethasone-induced	dexamethasone-induced	O	O	O	O
ocular	ocular	O	DISEASE	OTHERS	I
hypertension	hypertension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
perfusion-cultured	perfusion-cultured	O	O	O	O
human	human	O	O	O	O
eyes	eyes	O	O	O	O
.	.	O	O	O	O

PURPOSE	purpose	O	O	O	O
:	:	O	O	O	O
Glucocorticoid	glucocorticoid	O	O	O	O
administration	administration	O	O	O	O
can	can	O	O	O	O
lead	lead	O	O	OTHERS	I
to	to	O	O	O	O
the	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
ocular	ocular	O	DISEASE	OTHERS	I
hypertension	hypertension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
corticosteroid	corticosteroid	O	O	OTHERS	I
glaucoma	glaucoma	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
subset	subset	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
population	population	O	O	O	O
through	through	O	O	O	O
a	a	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
aqueous	aqueous	O	O	O	O
humor	humor	O	O	O	O
outflow	outflow	O	O	O	O
facility	facility	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
purpose	purpose	O	O	O	O
of	of	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
was	was	O	O	O	O
to	to	O	O	O	O
determine	determine	O	O	O	O
whether	whether	O	O	O	O
glucocorticoid	glucocorticoid	O	O	O	O
treatment	treatment	O	O	O	O
can	can	O	O	O	O
directly	directly	O	O	O	O
affect	affect	O	O	O	O
the	the	O	O	O	O
outflow	outflow	O	O	O	O
facility	facility	O	O	O	O
of	of	O	O	O	O
isolated	isolated	O	O	O	O
,	,	O	O	O	O
perfusion-cultured	perfusion-cultured	O	O	O	O
human	human	O	O	O	O
eyes	eyes	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
anterior	anterior	O	O	O	O
segments	segments	O	O	O	O
of	of	O	O	O	O
human	human	O	O	O	O
donor	donor	O	O	O	O
eyes	eyes	O	O	O	O
from	from	O	O	O	O
regional	regional	O	O	O	O
eye	eye	O	O	O	O
banks	banks	O	O	O	O
were	were	O	O	O	O
placed	placed	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
constant	constant	O	O	O	O
flow	flow	O	O	O	O
,	,	O	O	O	O
variable	variable	O	O	O	O
pressure	pressure	O	O	O	O
perfusion	perfusion	O	O	O	O
culture	culture	O	O	O	O
system	system	O	O	O	O
.	.	O	O	O	O

Paired	paired	O	O	O	O
eyes	eyes	O	O	O	O
were	were	O	O	O	O
perfused	perfused	O	O	O	O
in	in	O	O	O	O
serum-free	serum-free	O	O	O	O
media	media	O	O	O	O
with	with	O	O	O	O
or	or	O	O	O	O
without	without	O	O	O	O
10(-7	10(-7	O	O	O	O
)	)	O	O	O	O
M	m	O	O	O	O
dexamethasone	dexamethasone	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
12	12	O	O	O	O
days	days	O	O	O	O
.	.	O	O	O	O

Intraocular	intraocular	O	O	O	O
pressure	pressure	O	O	O	O
was	was	O	O	O	O
monitored	monitored	O	O	O	O
daily	daily	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
incubation	incubation	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
eyes	eyes	O	O	O	O
were	were	O	O	O	O
morphologically	morphologically	O	O	O	O
characterized	characterized	O	O	O	O
by	by	O	O	O	O
light	light	O	O	O	O
microscopy	microscopy	O	O	O	O
,	,	O	O	O	O
transmission	transmission	O	O	O	O
and	and	O	O	O	O
scanning	scanning	O	O	O	O
electron	electron	O	O	O	O
microscopy	microscopy	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
scanning	scanning	O	O	O	O
laser	laser	O	O	O	O
confocal	confocal	O	O	O	O
microscopy	microscopy	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
A	a	O	O	O	O
significant	significant	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
intraocular	intraocular	O	O	O	O
pressure	pressure	O	O	O	O
developed	developed	O	O	O	O
in	in	O	O	O	O
13	13	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
44	44	O	O	O	O
pairs	pairs	O	O	O	O
of	of	O	O	O	O
eyes	eyes	O	O	O	O
perfused	perfused	O	O	O	O
with	with	O	O	O	O
dexamethasone	dexamethasone	CHEMICALS	O	OTHERS	I
with	with	O	O	O	O
an	an	O	O	O	O
average	average	O	O	O	O
pressure	pressure	O	O	O	O
rise	rise	O	O	O	O
of	of	O	O	O	O
17.5	17.5	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
3.8	3.8	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
after	after	O	O	O	O
12	12	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
dexamethasone	dexamethasone	CHEMICALS	O	OTHERS	I
exposure	exposure	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
contralateral	contralateral	O	O	O	O
control	control	O	O	O	O
eyes	eyes	O	O	O	O
,	,	O	O	O	O
which	which	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
receive	receive	O	O	O	O
dexamethasone	dexamethasone	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
maintained	maintained	O	O	O	O
a	a	O	O	O	O
stable	stable	O	O	O	O
intraocular	intraocular	O	O	O	O
pressure	pressure	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
period	period	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
outflow	outflow	O	O	O	O
pathway	pathway	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
untreated	untreated	O	O	O	O
eyes	eyes	O	O	O	O
appeared	appeared	O	O	O	O
morphologically	morphologically	O	O	O	O
normal	normal	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
dexamethasone-treated	dexamethasone-treated	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
eyes	eyes	O	O	OTHERS	I
had	had	O	O	O	O
thickened	thickened	O	O	O	O
trabecular	trabecular	O	O	O	O
beams	beams	O	O	O	O
,	,	O	O	O	O
decreased	decreased	O	O	O	O
intertrabecular	intertrabecular	O	O	O	O
spaces	spaces	O	O	O	O
,	,	O	O	O	O
thickened	thickened	O	O	O	O
juxtacanalicular	juxtacanalicular	O	O	O	O
tissue	tissue	O	O	O	O
,	,	O	O	O	O
activated	activated	O	O	O	O
trabecular	trabecular	O	O	O	O
meshwork	meshwork	O	O	O	O
cells	cells	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
increased	increased	O	O	O	O
amounts	amounts	O	O	O	O
of	of	O	O	O	O
amorphogranular	amorphogranular	O	O	O	O
extracellular	extracellular	O	O	O	O
material	material	O	O	O	O
,	,	O	O	O	O
especially	especially	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
juxtacanalicular	juxtacanalicular	O	O	O	O
tissue	tissue	O	O	O	O
and	and	O	O	O	O
beneath	beneath	O	O	O	O
the	the	O	O	O	O
endothelial	endothelial	O	O	O	O
lining	lining	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
canal	canal	O	O	O	O
of	of	O	O	O	O
Schlemm	schlemm	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
dexamethasone-treated	dexamethasone-treated	O	O	O	O
nonresponder	nonresponder	O	O	O	O
eyes	eyes	O	O	O	O
appeared	appeared	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
morphologically	morphologically	O	O	O	O
similar	similar	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
untreated	untreated	O	O	O	O
eyes	eyes	O	O	O	O
,	,	O	O	O	O
although	although	O	O	O	O
several	several	O	O	O	O
subtle	subtle	O	O	O	O
dexamethasone-induced	dexamethasone-induced	O	O	O	O
morphologic	morphologic	O	O	O	O
changes	changes	O	O	O	O
were	were	O	O	O	O
evident	evident	O	O	O	O
.	.	O	O	O	O

CONCLUSION	conclusion	O	O	O	O
:	:	O	O	O	O
Dexamethasone	dexamethasone	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
of	of	O	O	O	O
isolated	isolated	O	O	O	O
,	,	O	O	O	O
perfusion-cultured	perfusion-cultured	O	O	O	O
human	human	O	O	O	O
eyes	eyes	O	O	O	O
led	led	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
generation	generation	O	O	O	O
of	of	O	O	O	O
ocular	ocular	O	DISEASE	OTHERS	I
hypertension	hypertension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
approximately	approximately	O	O	O	O
30	30	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
dexamethasone-treated	dexamethasone-treated	O	O	O	O
eyes	eyes	O	O	O	O
.	.	O	O	O	O

Steroid	steroid	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
resulted	resulted	O	O	O	O
in	in	O	O	O	O
morphologic	morphologic	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
trabecular	trabecular	O	O	O	O
meshwork	meshwork	O	O	O	O
similar	similar	O	O	O	O
to	to	O	O	O	O
those	those	O	O	O	O
reported	reported	O	O	O	O
for	for	O	O	O	O
corticosteroid	corticosteroid	O	O	OTHERS	I
glaucoma	glaucoma	O	DISEASE	OTHERS	I
and	and	O	O	O	O
open	open	O	O	OTHERS	I
angle	angle	O	O	OTHERS	I
glaucoma	glaucoma	O	DISEASE	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
system	system	O	O	O	O
may	may	O	O	O	O
provide	provide	O	O	O	O
an	an	O	O	O	O
acute	acute	O	O	O	O
model	model	O	O	O	O
in	in	O	O	O	O
which	which	O	O	O	O
to	to	O	O	O	O
study	study	O	O	O	O
the	the	O	O	O	O
pathogenic	pathogenic	O	O	O	O
mechanisms	mechanisms	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
steroid	steroid	CHEMICALS	O	OTHERS	I
glaucoma	glaucoma	O	DISEASE	OTHERS	I
and	and	O	O	O	O
primary	primary	O	O	OTHERS	I
open	open	O	O	OTHERS	I
angle	angle	O	O	OTHERS	I
glaucoma	glaucoma	O	DISEASE	OTHERS	I
.	.	O	O	O	O

